OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma
Ralf Gutzmer, James Solomon
Targeted Oncology (2019) Vol. 14, Iss. 3, pp. 253-267
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

The emergence of drug resistance to targeted cancer therapies: Clinical evidence
Ana Bela Sarmento‐Ribeiro, Andreas Scorilas, Ana Cristina Gonçalves, et al.
Drug Resistance Updates (2019) Vol. 47, pp. 100646-100646
Closed Access | Times Cited: 112

New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
Alessia Villani, Luca Potestio, Gabriella Fabbrocini, et al.
Advances in Therapy (2022) Vol. 39, Iss. 3, pp. 1164-1178
Open Access | Times Cited: 55

Gorlin Syndrome: Recent Advances in Genetic Testing and Molecular and Cellular Biological Research
Shoko Onodera, Yuriko Nakamura, Toshifumi Azuma
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7559-7559
Open Access | Times Cited: 55

Pharmaceutical Formulations Containing Graphene and 5-Fluorouracil for Light-Emitting Diode-Based Photochemotherapy of Skin Cancer
Sara I. Amaral, Filipa A. L. S. Silva, Raquel Costa‐Almeida, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 4, pp. 4333-4347
Closed Access | Times Cited: 8

A paracrine activin A–mDia2 axis promotes squamous carcinogenesis via fibroblast reprogramming
Michael Cangkrama, Mateusz S. Wietecha, Nicolas Mathis, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 4
Open Access | Times Cited: 48

Performance of Ultrasound for Identifying Morphological Characteristics and Thickness of Cutaneous Basal Cell Carcinoma: A Systematic Review
Alexandra Laverde‐Saad, Alexe Simard, David Nassim, et al.
Dermatology (2022) Vol. 238, Iss. 4, pp. 692-710
Open Access | Times Cited: 28

Beyond the adverse effects of the systemic route: Exploiting nanocarriers for the topical treatment of skin cancers
Beatriz da Silva Gomes, Ana Cláudia Paiva‐Santos, Francisco Veiga, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115197-115197
Open Access | Times Cited: 5

<p>A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells</p>
Hong-Juan Yao, Lan Sun, Jingcao Li, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 7013-7034
Open Access | Times Cited: 34

Sea Urchin as a Universal Model for Studies of Gene Networks
Leonid Adonin, А. Л. Дроздов, Nickolai A. Barlev
Frontiers in Genetics (2021) Vol. 11
Open Access | Times Cited: 28

Xeroderma Pigmentosum: A Genetic Condition Skin Cancer Correlated—A Systematic Review
Tito Brambullo, Michele Rosario Colonna, Vincenzo Vindigni, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 22

Recent Advances in Signaling Pathways Comprehension as Carcinogenesis Triggers in Basal Cell Carcinoma
Mircea Tampa, Simona Roxana Georgescu, Cristina Iulia Mitran, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 3010-3010
Open Access | Times Cited: 28

Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma
Hung Q. Doan, Leon Chen, Zeena Y. Nawas, et al.
Oncotarget (2021) Vol. 12, Iss. 20, pp. 2089-2100
Open Access | Times Cited: 26

Trophoblast cell surface antigen 2 expression in scalp basal cell carcinomas: does it differ from the facial basal cell carcinomas location?
Fatma Alzahraa Abdelsalam Elkhamisy, Ahmed Naeem Eesa, Nadia Ahmed Abd El-Moeze
Egyptian Journal of Dermatology and Venerology (2025) Vol. 45, Iss. 1, pp. 41-48
Closed Access

The Adhesion GPCR ADGRL2 engages Gα13 to Enable Epidermal Differentiation
Xue Yang, Feng He, Douglas F. Porter, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Chirurgia dei tumori cutanei
V. Duquennoy-Martinot, E. Maze, A. Belkhou, et al.
EMC - Tecniche Chirurgiche - Chirurgia Plastica¸ Ricostruttiva ed Estetica (2025) Vol. 23, Iss. 1, pp. 1-28
Closed Access

Hedgehog signaling pathway inhibitors in the treatment of basal cell carcinoma: An Updated Review
Adela Markota Čagalj, Mislav Glibo, Valentina Karin‐Kujundžić, et al.
Journal of drug targeting (2025), pp. 1-49
Closed Access

Patidegib in Dermatology: A Current Review
Terenzio Cosio, Monia Di Prete, Cosimo Di Raimondo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10725-10725
Open Access | Times Cited: 20

Emerging roles of the Hedgehog signalling pathway in inflammatory bowel disease
Zhuo Xie, Mudan Zhang, Gaoshi Zhou, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 18

Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance
RF. Zaarour, Marcelo Lima Ribeiro, Bruno Azzarone, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8

Eradicating the tumor “seeds”: nanomedicines-based therapies against cancer stem cells
Lin Li, Rui Ni, Dan Zheng, et al.
DARU Journal of Pharmaceutical Sciences (2023) Vol. 31, Iss. 1, pp. 83-94
Open Access | Times Cited: 7

Ageing and cancer: a research gap to fill
Éric Solary, Nancy Abou-Zeid, Fabien Calvo
Molecular Oncology (2022) Vol. 16, Iss. 18, pp. 3220-3237
Open Access | Times Cited: 12

Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect
Carlo Tomasini, Giacomo Fiandrino, E Favale, et al.
Dermatopathology (2024) Vol. 11, Iss. 2, pp. 154-160
Open Access | Times Cited: 2

Oral Hedgehog Inhibitor, Vismodegib, for Locally Advanced Periorbital and Orbital Basal Cell Carcinoma
Edward J. Wladis, Vinay K. Aakalu, M. Reza Vagefi, et al.
Ophthalmology (2024) Vol. 131, Iss. 11, pp. 1339-1344
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top